Drug Shortage Report for NOVAMOXIN

Last updated on 2022-09-23 History
Report ID 169966
Drug Identification Number 00452130
Brand name NOVAMOXIN
Common or Proper name TEVA-AMOXICILLIN SUS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) AMOXICILLIN
Strength(s) 250MG
Dosage form(s) GRANULES FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100,150
ATC code J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-22
Estimated end date 2022-11-10
Actual end date
Shortage status Actual shortage
Updated date 2022-09-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-09-23 English Compare
v2 2022-09-22 French Compare
v1 2022-09-22 English Compare

Showing 1 to 3 of 3